In the same context, previous studies have demonstrated that TGFBR1 acts as a potent modifier of cancer risk, and TGFBR1 overexpression has been associated with cancer cell aggressiveness and poor clinical outcomes in many malignancies [20,21,22,23,24]. The gene discussed is TGFBR1; the disease is cancer.